MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 56 filers reported holding MARRONE BIO INNOVATIONS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $39,000 | +44.4% | 33,769 | 0.0% | 0.14% | +921.4% |
| Q1 2020 | $27,000 | -53.4% | 33,769 | -41.7% | 0.01% | +100.0% |
| Q4 2019 | $58,000 | -33.3% | 57,900 | -6.9% | 0.01% | -36.4% |
| Q3 2019 | $87,000 | -13.0% | 62,200 | -6.7% | 0.01% | +57.1% |
| Q2 2019 | $100,000 | -31.0% | 66,700 | -29.8% | 0.01% | 0.0% |
| Q1 2019 | $145,000 | +54.3% | 95,000 | +47.5% | 0.01% | +16.7% |
| Q4 2018 | $94,000 | -43.0% | 64,400 | -28.5% | 0.01% | -40.0% |
| Q2 2018 | $165,000 | +1000.0% | 90,100 | +572.4% | 0.01% | +900.0% |
| Q3 2017 | $15,000 | -80.8% | 13,400 | -78.0% | 0.00% | -80.0% |
| Q2 2017 | $78,000 | -35.5% | 60,800 | -2.1% | 0.01% | -37.5% |
| Q1 2017 | $121,000 | -29.7% | 62,107 | -22.8% | 0.01% | -42.9% |
| Q4 2016 | $172,000 | +364.9% | 80,500 | +265.9% | 0.01% | +366.7% |
| Q3 2016 | $37,000 | -80.6% | 22,000 | +93.0% | 0.00% | -93.2% |
| Q3 2013 | $191,000 | – | 11,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 14,303,099 | $15,635,000 | 3.02% |
| ICM ASSET MANAGEMENT INC/WA | 21,500 | $26,000 | 0.14% |
| Fairpointe Capital LLC | 613,900 | $749,000 | 0.12% |
| WADDELL & REED FINANCIAL INC | 25,095,634 | $30,617,000 | 0.07% |
| WEDBUSH SECURITIES INC | 37,129 | $45,000 | 0.00% |
| Financial Advocates Investment Management | 30,925 | $38,000 | 0.00% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,035,300 | $2,483,000 | 0.00% |
| Avior Wealth Management, LLC | 10,000 | $12,000 | 0.00% |
| AMALGAMATED BANK | 10,217 | $12,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 73,897 | $90,000 | 0.00% |